Korean medical AI company Lunit raises KRW 200 Billion to accelerate global expansion
Lunit, a leading Korean medical AI company, has raised KRW 200 billion in funding to accelerate its global expansion. The funding will be used to support the development of new products, expand into new markets, and hire new employees.
Lunit plans to use the funds as follows:
- Investments in affiliated companies: KRW 90.7 billion to expand into global markets and establish a corporate venture capital (CVC). The CVC will focus on long-term revenue generation, strategic mergers and acquisitions (M&A), and investments in global medical AI startups.
- Product development and new product development: KRW 50.7 billion to improve existing products and develop new products.
- New business development: KRW 40 billion to explore new business opportunities based on medical AI.
- Hiring overseas employees: KRW 20.4 billion to hire overseas employees for global expansion.
Lunit’s largest shareholder, Chairman Baek Seung-wook, and CEO Seo Beom-seok, as well as other key executives, will participate in the rights issue at 100%. This shows the company’s commitment to global expansion and growth.
- Didim365 Secures Naver Cloud Investment, Accelerates AI and Digital Transformation
- Airbility is selected for KODIT’s “Little Penguin” and “Startup NEST” support programs
- 01Republic Secures Funding to Expand the SaaS Management Solution ‘Scordi’
- AI Startup BFAI Secures Seed Funding to Expand WhaleAI Marketplace for SMBs
- Chabot Mobility Acquires SK Networks’ ‘The Carpet’ to Enhance Vehicle Management
- Nullee Raises KRW 5B in Series B to Enhance SSEM Tax Filing Service and Expand
- Rexpharm Forms MOU with Timely Basket to Develop and Distribute Health Foods in U.S.
- Tokyo Hosts ‘SusHi Tech 2024’ in May to Foster Global Startup Innovation for Sustainable Cities
- ModuSign Secures 17.7 Billion KRW Series C Investment for E-contract Solutions
- [Korean Startup Weekly News #15] ‘Startup Korea Fund’ launched with KRW 500 billion from government and private investors
